Using a Virtual Care Platform to Deliver Peer-led Mental Health Support to Rural and Remote Communities in BC: a Randomized Wait-list Controlled Trial of the REACHOUT Intervention
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 225
- Locations
- 1
- Primary Endpoint
- Change in Diabetes Distress
Study Overview
Brief Summary
The purpose of this study is to investigate the effectiveness of participation in a 6-month peer-led mental health support program, delivered via a mobile app (REACHOUT), to adults with type 1 diabetes compared to a wait-list control condition. Participants will connect with a Peer-Supporter (an adult with type 1 diabetes trained in providing mental health support), and have access to the app features including a 24/7 chat room and face-to-face support delivered via virtual happy hours.
Detailed Description
REACHOUT is a mobile app which delivers peer-led mental health support to adults with type 1 diabetes. The mobile app has three support features:
- One-on-one support delivered by a Peer Supporter
Peer Supporters are adults with type 1 diabetes who will be trained on providing support to other adults with type 1 diabetes on the app ("the participants"). Participants will be able to go through the peer supporter library, review their profiles, and choose their peer supporter. 2. Group support delivered via a 24/7 chat room
Peer Supporters and participants on the app will be able to chat 24/7 in the chat room about any topic ranging from feedback on new devices to traveling with diabetes. The chat room is monitored by healthcare professionals including a registered nurse and registered psychologist. 3. Face to face support delivered via virtual happy hours
Virtual happy hours are educational presentations/discussions led by either a Peer Supporter or healthcare professional on topics related to diabetes.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 19 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •have type 1 diabetes (T1D)
- •be 19 years or older
- •reside in one of the targeted health authorities in British Columbia (Fraser Health, Island Health, Northern Health, and Interior Health Authorities)
- •be English proficient
- •have an average diabetes distress (DD) Subscale Score ≥ 2
- •have access to the internet and/or a smartphone.
Exclusion Criteria
- •Participants with a pre-existing mental health condition, multiple co-morbidities, substance use challenges, and or any other condition that may prevent meaningful participation may not participate in this study.
Outcomes
Primary Outcomes
Change in Diabetes Distress
Time Frame: 0, 6 month(s)
Diabetes Distress will be measured by the Type 1 Diabetes Distress Scale (T1D-DDS). This scale contains 28 items that people with type 1 diabetes may find distressing. Participants rate each item on a scale from 1 indicating Not a Problem to 6 indicating a Very Serious Problem. There are seven subscales including powerlessness, management distress, hypoglycemia distress, negative social distress, eating distress, physician distress, and family/friends distress. Overall and subscale scores are calculated by taking the mean of items in the overall or subscale. A higher score indicates higher diabetes distress.
Secondary Outcomes
- Change in Perceived social support(0, 6 month(s))
- Change in Depressive Symptom Severity(0, 6 month(s))
- Change in Resilience(0, 6 month(s))
- Change in Diabetes-Specific Quality of Life(0, 6 month(s))
- Change in Health-Related Quality of Life(0, 3, 6 month(s))
- Change in Quality Adjusted Life year (QALY)(0, 3, 6 month(s))
- Change in Health Related Costs(0, 3, 6 month(s))
- Change in Hemoglobin A1c(0, 6 month(s))
- Change in % Time in Range(14 days before and after each participant's baseline and 6-month assessments, respectively)
Investigators
Tricia Tang
Principal Investigator
University of British Columbia